James D Fisher
Overview
Explore the profile of James D Fisher including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
82
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Egro F, Schilling B, Fisher J, Saadoun R, Rubin J, Marra K, et al.
J Hand Microsurg
. 2024 Jun;
16(1):100011.
PMID: 38854368
Background: Microsurgical techniques have revolutionized the field of reconstructive surgery and are the mainstay for complex soft tissue reconstruction. However, their limitations have promoted the development of viable alternatives. This...
2.
Fisher J, Zhang W, Balmert S, Aral A, Acharya A, Kulahci Y, et al.
Sci Adv
. 2020 Mar;
6(11):eaax8429.
PMID: 32201714
Vascularized composite allotransplantation (VCA) encompasses face and limb transplantation, but as with organ transplantation, it requires lifelong regimens of immunosuppressive drugs to prevent rejection. To achieve donor-specific immune tolerance and...
3.
Fisher J, Balmert S, Zhang W, Schweizer R, Schnider J, Komatsu C, et al.
Proc Natl Acad Sci U S A
. 2019 Dec;
116(51):25784-25789.
PMID: 31792185
For individuals who sustain devastating composite tissue loss, vascularized composite allotransplantation (VCA; e.g., hand and face transplantation) has the potential to restore appearance and function of the damaged tissues. As...
4.
Fisher J, Acharya A, Little S
Clin Immunol
. 2015 May;
160(1):24-35.
PMID: 25937032
Despite decades of advances in transplant immunology, tissue damage caused by acute allograft rejection remains the primary cause of morbidity and mortality in the transplant recipient. Moreover, the long-term sequelae...
5.
DiLeo M, Fisher J, Burton B, Federspiel W
J Biomed Mater Res B Appl Biomater
. 2010 Nov;
96(1):127-33.
PMID: 21086427
Sepsis is a harmful hyper-inflammatory state characterized by overproduction of cytokines. Removal of these cytokines using an extracorporeal device is a potential therapy for sepsis. We are developing a cytokine...
6.
DiLeo M, Fisher J, Federspiel W
Ann Biomed Eng
. 2009 Aug;
37(11):2310-6.
PMID: 19680812
Sepsis, a systemic inflammatory response in the presence of an infection, is characterized by overproduction of inflammatory mediators called cytokines. Removal of these cytokines using an extracorporeal hemoadsorption device is...
7.
Mason M, Perkins A, Matthews R, Fisher J, Mashuta M, Vij A
Inorg Chem
. 2001 Oct;
37(15):3734-3746.
PMID: 11670473
THF/toluene solutions of phosphonic or phosphoric acids were reacted with (t)Bu(3)Ga at low temperature to yield the cyclic dimers [(t)Bu(2)GaO(2)P(OH)R](2) (R = Ph, Me, (t)Bu, H, OH; 1-5). Poor crystallinity...
8.
Fisher J, Shapiro P, Budzelaar P, Staples R
Inorg Chem
. 2001 Oct;
37(6):1295-1298.
PMID: 11670336
The cyclopentadienylaluminum aryloxide derivatives bis(cyclopentadienyl)(2,6-di-tert-butyl-4-methylphenoxy)aluminum (1) and (eta(5)-cyclopentadienyl)bis(2,6-di-tert-butyl-4-methylphenoxy)aluminum (2) have been prepared via the alcoholysis of tricyclopentadienylaluminum with 2,6-di-tert-butyl-4-methylphenol. The X-ray crystal structure of 2 was determined. The molecule crystallizes...
9.
Fisher J, Shapiro P, Yap G, Rheingold A
Inorg Chem
. 1996 Jan;
35(2):271-272.
PMID: 11666201
No abstract available.